OXR1 and Parkinson disease: Interestingly, the deregulation of the TLDc family has been demonstrated in several disease states, including an increase in OXR1 protein expression in end-stage ALS spinal cord biopsies (8) and a reduction in OXR1 in the posterior cingulate cortex of patients with Parkinson disease (51).